ECS Botanics Holdings (ASX:ECS) OCF Yield %: -49.14 (As of Jun. 26, 2026)


What is ECS Botanics Holdings OCF Yield %?

ECS Botanics Holdings ASX:ECS OCF Yield % is -49.14 as of Jun. 26, 2026. The stock has 9 warning signs investors should review. Among 1,005 Drug Manufacturers companies, ECS Botanics Holdings ranks worse than 95.52% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, ECS Botanics Holdings's Trailing 12-Month Cash Flow from Operations is A$-3.53 Mil, and Market Cap is A$6.38 Mil. Therefore, ECS Botanics Holdings's OCF Yield % for today is -49.14%.

The historical rank and industry rank for ECS Botanics Holdings's OCF Yield % or its related term are showing as below:

ASX:ECS' s OCF Yield % Range Over the Past 10 Years
Min: -99.67   Med: -15.04   Max: 2.28
Current: -49.14


During the past 13 years, the highest OCF Yield % of ECS Botanics Holdings was 2.28%. The lowest was -99.67%. And the median was -15.04%.

ASX:ECS's OCF Yield % is ranked worse than
95.52% of 1005 companies
in the Drug Manufacturers industry
Industry Median: 3.61 vs ASX:ECS: -49.14

ECS Botanics Holdings's OCF Margin % for the quarter that ended in Dec. 2025 was %.


ECS Botanics Holdings OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


ECS Botanics Holdings OCF Yield % Related Terms


ECS Botanics Holdings OCF Yield % Historical Data

* Premium members only.

The historical data trend for ECS Botanics Holdings's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ECS Botanics Holdings OCF Yield % Chart

ECS Botanics Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -7.29 -25.05 1.46 -6.78 -43.48

ECS Botanics Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.40 -17.43 -10.75 -66.68 6.94

ASX:ECS vs ZTS: OCF Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ECS Botanics Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ECS Botanics Holdings OCF Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ECS Botanics Holdings's OCF Yield % distribution charts can be found below:

* The bar in red indicates where ECS Botanics Holdings's OCF Yield % falls into.



ECS Botanics Holdings OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

ECS Botanics Holdings's OCF Yield % for the fiscal year that ended in Jun. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-5.072 / 11.66445
=-43.48%

ECS Botanics Holdings's annualized OCF Yield % for the quarter that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0.36 * 2 / 10.374325
=6.94%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -49.14 mean?
ECS Botanics Holdings (ASX:ECS) has a OCF Yield % of -49.14 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ECS Botanics Holdings and its competitors. According to the industry distribution chart, ECS Botanics Holdings ranks #960 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 95.5%.
Is ECS Botanics Holdings' OCF Yield % too high?
ECS Botanics Holdings' current OCF Yield % is -49.14. Based on the distribution chart, ECS Botanics Holdings ranks #960 out of 1005 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does ECS Botanics Holdings' OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, ECS Botanics Holdings ranks #960 out of 1005 companies for OCF Yield %. This places ECS Botanics Holdings in the lower half of its industry. The industry median OCF Yield % is 3.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on ECS Botanics Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ECS Botanics Holdings's current OCF Yield % is -49.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ECS Botanics Holdings stock overvalued right now?
Based on GuruFocus' analysis, ECS Botanics Holdings (ASX:ECS) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 80% below its estimated fair value. The current OCF Yield % is -49.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For ECS Botanics Holdings (ASX:ECS), the current OCF Yield % is -49.14 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ECS Botanics Holdings Business Description

Address 899 River Road, Murrabit West, Murrabit, VIC, AUS, 3579
ECS Botanics Holdings Ltd is an Australian medicinal cannabis cultivator and manufacturer located in Northwest Victoria. The company utilizes progressive cultivation methodologies to produce quality medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. Licensed by the Therapeutic Drug Administration to manufacture PIC/S GMP certified products, the company provides quality, affordable medicinal cannabis, supplying both local and overseas markets.